Related Experiment Video
Updated: Oct 22, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Structural insights into ligand recognition and activation of the melanocortin-4 receptor
Huibing Zhang1,2,3,4, Li-Nan Chen1,2,3,4, Dehua Yang5,6,7
1Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Abstract:
Melanocortin-4 receptor (MC4R) plays a central role in the regulation of energy homeostasis. Its high sequence similarity to other MC receptor family members, low agonist selectivity and the lack of structural information concerning MC4R-specific activation have hampered the development of MC4R-seletive therapeutics to treat obesity. Here, we report four high-resolution structures of full-length MC4R in complex with the heterotrimeric Gs protein stimulated by the endogenous peptide ligand α-MSH, FDA-approved drugs afamelanotide (Scenesse™) and bremelanotide (Vyleesi™), and a selective small-molecule ligand THIQ, respectively. Together with pharmacological studies, our results reveal the conserved binding mode of peptidic agonists, the distinctive molecular details of small-molecule agonist recognition underlying receptor subtype selectivity, and a distinct activation mechanism for MC4R, thereby offering new insights into G protein coupling. Our work may facilitate the discovery of selective therapeutic agents targeting MC4R.
Insights
Researchers uncovered the structure of the Melanocortin-4 receptor (MC4R) bound to various molecules. This provides crucial insights into how MC4R is activated, potentially aiding the development of new obesity treatments.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- The Melanocortin-4 receptor (MC4R) is vital for regulating energy balance.
- Challenges in MC4R drug development stem from its similarity to other receptors and lack of structural data.
Purpose of the Study:
- To determine the high-resolution structures of MC4R in complex with Gs protein.
- To elucidate the molecular mechanisms of MC4R activation by different ligands.
Main Methods:
- X-ray crystallography to obtain high-resolution structures.
- Pharmacological studies to assess ligand binding and receptor activation.
Main Results:
- Structures of MC4R complexed with Gs protein, α-MSH, afamelanotide, bremelanotide, and THIQ were determined.
- Conserved binding modes for peptide agonists and distinct recognition for small molecules were revealed.
- A unique MC4R activation mechanism and G protein coupling insights were uncovered.
Conclusions:
- Structural and pharmacological data illuminate MC4R activation and selectivity.
- Findings pave the way for designing selective MC4R therapeutics for obesity and related metabolic disorders.
More Related Videos
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
09:30Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Opioid Receptors: Overview
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Internal Receptors